73 results
Page 2 of 4
S-3
09pq a56ctsmclke
17 Oct 23
Shelf registration
5:01pm
8-K
kyu7p32la43
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-99.1
w40yrwtoexgak
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-10.1
8ljjo4ht lq
12 Oct 23
Submission of Matters to a Vote of Security Holders
4:26pm
424B3
1tw 2nvdku
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
n0gqplr9rb f7
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
425
uszn6dbux 0remt
9 Jun 23
Business combination disclosure
4:31pm
425
4em7gy63t7cvg64jg
17 May 23
Business combination disclosure
4:54pm
S-4
EX-10.11
bc1arjmu8n30qd187ve
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
q622axq61plp
11 May 23
Registration of securities issued in business combination transactions
9:09am
425
w3du94a4k
18 Apr 23
Business combination disclosure
5:12pm
6-K
EX-99.1
ogo4r8sp xe2bj5roz
19 Jul 22
VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancer
4:09pm
6-K
EX-99.2
ropvbq
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-1.1
nlr7l01
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.3
lpj0mzca3l5z
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
6-K
EX-99.2
l6h8622ceypizcz53q
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am